The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Nuvo Research Inc up sharply

Nuvo Research Inc closed up sharply Friday, rallying $0.08 or 1.90% to $4.30. Although unchanged over the last five days, shares are down 38.57% for the last year to date. This security has outperformed the S&P TSX by 62.20% during the last year.

Key company metrics

  • Trailing P/E1.16×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$3.69
Updated March 27 3:41 PM EDT. Delayed by at least 15 minutes.


Net Profit (TTM)

Based on its net profit margin of 295.55%, Nuvo Research Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.39%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Total other revenue--------
Total revenue3343
Gross profit2222
Total cost of revenue2111
Total operating expense10-4666
Selling / general / administrative4332
Research & development3212
Depreciation / amortization0000
Interest expense (income), net operating0000
Unusual expense (income)2-52----
Other operating expenses, total--------
Operating income-749-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets0------
Income before tax-650-2-3
Income after tax-650-2-3
Income tax, total0000
Net income-650-2-3
Total adjustments to net income--------
Net income before extra. items-650-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-650-2-3
Inc. avail. to common incl. extra. items-650-2-3
Diluted net income-650-2-3
Dilution adjustment--0--0
Diluted weighted average shares1110109
Diluted EPS excluding extraordinary itemsvalue per share-0.574.80-0.23-0.31
Dividends per sharevalue per share--
Diluted normalized EPSvalue per share-0.491.52-0.23-0.31